Ruptured PICA aneurysms: presentation and treatment outcomes compared to other posterior circulation aneurysms. A Swiss SOS study.


Journal

Acta neurochirurgica
ISSN: 0942-0940
Titre abrégé: Acta Neurochir (Wien)
Pays: Austria
ID NLM: 0151000

Informations de publication

Date de publication:
07 2019
Historique:
received: 06 02 2019
accepted: 25 03 2019
pubmed: 27 4 2019
medline: 14 4 2020
entrez: 27 4 2019
Statut: ppublish

Résumé

Aneurysms of the posterior inferior cerebellar artery (PICA) are relatively uncommon and evidence is sparse about patients presenting with ruptured PICA aneurysms. We performed an analysis of the Swiss SOS national registry to describe clinical presentation, treatment pattern, and neurological outcome of patients with ruptured PICA aneurysms compared with other ruptured posterior circulation (PC) aneurysms. This was a retrospective analysis of anonymized data from the Swiss SOS registry (Swiss Study on Aneurysmal Subarachnoid Hemorrhage; 2009-2014). Patients with ruptured PC aneurysms were subdivided into a PICA and non-PICA group. Clinical, radiological, and treatment-related variables were identified, and their impact on the neurological outcome was determined in terms of modified Rankin score at discharge and at 1 year of follow-up for the two groups. Data from 1864 aneurysmal subarachnoid hemorrhage patients were reviewed. There were 264 patients with a ruptured PC aneurysm. Seventy-four PICA aneurysms represented 28% of the series; clinical and radiological characteristics at admission were comparable between the PICA and non-PICA group. Surgical treatment was accomplished in 28% of patients in the PICA group and in the 4.8% of patients in the non-PICA group. No statistically significant difference was found between the two groups in terms of complications after treatment. Hydrocephalus requiring definitive shunt was needed in 21.6% of PICA patients (p = 0.6); cranial nerve deficit was present in average a quarter of the patients in both PICA and non-PICA group with no statistical difference (p = 0.3). A more favorable outcome (66.2%) was reported in the PICA group at discharge (p < 0.05) but this difference faded over time with a similar neurological outcome at 1-year follow-up (p = 0.09) between both PICA and non-PICA group. The Kaplan-Meyer estimation showed no significant difference in the mortality rate between both groups (p = 0.08). In the present study, patients with ruptured PICA aneurysms had a favorable neurological outcome in more than two thirds of cases, similar to patients with other ruptured PC aneurysms. Surgical treatment remains a valid option in a third of cases with ruptured PICA aneurysms.

Sections du résumé

BACKGROUND AND PURPOSE
Aneurysms of the posterior inferior cerebellar artery (PICA) are relatively uncommon and evidence is sparse about patients presenting with ruptured PICA aneurysms. We performed an analysis of the Swiss SOS national registry to describe clinical presentation, treatment pattern, and neurological outcome of patients with ruptured PICA aneurysms compared with other ruptured posterior circulation (PC) aneurysms.
METHODS
This was a retrospective analysis of anonymized data from the Swiss SOS registry (Swiss Study on Aneurysmal Subarachnoid Hemorrhage; 2009-2014). Patients with ruptured PC aneurysms were subdivided into a PICA and non-PICA group. Clinical, radiological, and treatment-related variables were identified, and their impact on the neurological outcome was determined in terms of modified Rankin score at discharge and at 1 year of follow-up for the two groups.
RESULTS
Data from 1864 aneurysmal subarachnoid hemorrhage patients were reviewed. There were 264 patients with a ruptured PC aneurysm. Seventy-four PICA aneurysms represented 28% of the series; clinical and radiological characteristics at admission were comparable between the PICA and non-PICA group. Surgical treatment was accomplished in 28% of patients in the PICA group and in the 4.8% of patients in the non-PICA group. No statistically significant difference was found between the two groups in terms of complications after treatment. Hydrocephalus requiring definitive shunt was needed in 21.6% of PICA patients (p = 0.6); cranial nerve deficit was present in average a quarter of the patients in both PICA and non-PICA group with no statistical difference (p = 0.3). A more favorable outcome (66.2%) was reported in the PICA group at discharge (p < 0.05) but this difference faded over time with a similar neurological outcome at 1-year follow-up (p = 0.09) between both PICA and non-PICA group. The Kaplan-Meyer estimation showed no significant difference in the mortality rate between both groups (p = 0.08).
CONCLUSIONS
In the present study, patients with ruptured PICA aneurysms had a favorable neurological outcome in more than two thirds of cases, similar to patients with other ruptured PC aneurysms. Surgical treatment remains a valid option in a third of cases with ruptured PICA aneurysms.

Identifiants

pubmed: 31025178
doi: 10.1007/s00701-019-03894-5
pii: 10.1007/s00701-019-03894-5
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1325-1334

Investigateurs

Alda Rocca (A)
Bruno Bartolini (B)
Steven Hajdu (S)
Francesco Puccinelli (F)
Kulcsàr Zsolt (K)
Emanuela Keller (E)
Luca Regli (L)
Oliver Bozinov (O)
Sina Finkenstädt (S)
Daniel Schöni (D)
Andreas Raabe (A)
Jürgen Beck (J)
Johannes Goldberg (J)
Luigi Mariani (L)
Raphael Guzman (R)
Javier Fandino (J)
Daniel Coluccia (D)
Alessandro Cianfoni (A)
Daniele Valsecchi (D)
Alessio Chiappini (A)
Alice Venier (A)
Michael Reinert (M)
Johannes Weber (J)
Andrea Ferrari (A)
Astrid Weyerbrock (A)
Gerhard Hildebrandt (G)
Martin Hlavica (M)
Vitor Mendes Pereira (VM)
Marco Corniola (M)
Karl Schaller (K)

Commentaires et corrections

Type : ErratumIn

Auteurs

Daniele Starnoni (D)

Department of Clinical Neurosciences, Service of Neurosurgery, Lausanne University Hospital (CHUV), 46 rue du Bugnon, 1011, Lausanne, Switzerland.

Rodolfo Maduri (R)

Department of Clinical Neurosciences, Service of Neurosurgery, Lausanne University Hospital (CHUV), 46 rue du Bugnon, 1011, Lausanne, Switzerland. rodolfo.maduri@gmail.com.

Khalid Al Taha (K)

Department of Clinical Neurosciences, Service of Neurosurgery, Lausanne University Hospital (CHUV), 46 rue du Bugnon, 1011, Lausanne, Switzerland.

David Bervini (D)

Department of Neurosurgery, Inselspital, University of Bern, Bern, Switzerland.

Daniel Walter Zumofen (DW)

Department of Neurosurgery, Basel University Hospital, Basel, Switzerland.
Diagnostic and Interventional Neuroradiology Section, Department of Radiology, Basel University Hospital, Basel, Switzerland.

Martin Nikolaus Stienen (MN)

Department of Neurosurgery, University Hospital of Zurich and Clinical Neurosciences Center, University of Zurich, Zurich, Switzerland.

Bawarjan Schatlo (B)

Department of Neurosurgery, University Hospital Göttingen, Göttingen, Germany.

Christian Fung (C)

Department of Neurosurgery, Medical Center, University of Freiburg, Freiburg, Germany.

Thomas Robert (T)

Department of Neurosurgery, Ospedale Civico di Lugano, Lugano, Switzerland.

Martin A Seule (MA)

Department of Neurosurgery, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Jan-Karl Burkhardt (JK)

Department of Neurosurgery, University Hospital of Zurich and Clinical Neurosciences Center, University of Zurich, Zurich, Switzerland.
Department of Neurosurgery, Baylor Medical Center and College of Medicine, Houston, TX, USA.

Nicolai Maldaner (N)

Department of Neurosurgery, University Hospital of Zurich and Clinical Neurosciences Center, University of Zurich, Zurich, Switzerland.

Michel Rothlisberger (M)

Department of Neurosurgery, Basel University Hospital, Basel, Switzerland.

Kristine A Blackham (KA)

Diagnostic and Interventional Neuroradiology Section, Department of Radiology, Basel University Hospital, Basel, Switzerland.

Serge Marbacher (S)

Department of Neurosurgery, Kantonsspital Aarau, Aarau, Switzerland.

Donato D'Alonzo (D)

Department of Neurosurgery, Kantonsspital Aarau, Aarau, Switzerland.

Luca Remonda (L)

Department of Radiology, Division of Diagnostic and Interventional Neuroradiology, Kantonsspital Aarau, Aarau, Switzerland.

Paolo Machi (P)

Department of Radiology, Division of Diagnostic and Interventional Neuroradiology, Geneva University Hospital (HUG), Geneva, Switzerland.

Jan Gralla (J)

Department of Radiology, Division of Diagnostic and Interventional Neuroradiology, Inselspital, University of Bern, Bern, Switzerland.

Philippe Bijlenga (P)

Department of Neurosurgery, Hopitaux Universitaires Genève, Geneva, Switzerland.

Guillaume Saliou (G)

Department of Radiology, Division of Diagnostic and Interventional Neuroradiology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

Pierluigi Ballabeni (P)

Lausanne Institute for Clinical Epidemiology and Biostatistics, University Hospital Lausanne (CHUV), Lausanne, Switzerland.
University of Lausanne (UniL), Lausanne, Switzerland.

Marc Levivier (M)

Department of Clinical Neurosciences, Service of Neurosurgery, Lausanne University Hospital (CHUV), 46 rue du Bugnon, 1011, Lausanne, Switzerland.
University of Lausanne (UniL), Lausanne, Switzerland.

Mahmoud Messerer (M)

Department of Clinical Neurosciences, Service of Neurosurgery, Lausanne University Hospital (CHUV), 46 rue du Bugnon, 1011, Lausanne, Switzerland.
University of Lausanne (UniL), Lausanne, Switzerland.

Roy Thomas Daniel (RT)

Department of Clinical Neurosciences, Service of Neurosurgery, Lausanne University Hospital (CHUV), 46 rue du Bugnon, 1011, Lausanne, Switzerland.
University of Lausanne (UniL), Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH